Truncated ETV1, Fused to Novel Tissue-Specific Genes, and Full-Length ETV1 in Prostate CancerHERMANS, Karin G; VAN DER KORPUT, Hetty A; KORSTEN, Hanneke et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 18, pp 7541-7549, issn 0008-5472, 9 p.Article

A Distinctive DNA Damage Response in Human Hematopoietic Stem Cells Reveals an Apoptosis-Independent Role for p53 in Self-RenewalMILYAVSKY, Michael; GAN, Olga I; ORNATSKY, Olga et al.Cell stem cell. 2010, Vol 7, Num 2, pp 186-197, issn 1934-5909, 12 p.Article

Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate CancerHERMANS, Karin G; BOORMANS, Joost L; GASI, Delila et al.Clinical cancer research (Print). 2009, Vol 15, Num 20, pp 6398-6403, issn 1078-0432, 6 p.Article

Expression of the Androgen-Regulated Fusion Gene TMPRSS2-ERG Does Not Predict Response to Endocrine Treatment in Hormone-Naïve, Node-Positive Prostate CancerBOORMANS, Joost L; HERMANS, Karin G; ZIEL-VAN DER MADE, Angelique C. J et al.European urology. 2010, Vol 57, Num 5, pp 830-835, issn 0302-2838, 6 p.Article

TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancerHERMANS, Karin G; VAN MARION, Ronald; VAN DEKKEN, Herman et al.Cancer research (Baltimore). 2006, Vol 66, Num 22, pp 10658-10663, issn 0008-5472, 6 p.Article

Androgen receptor modifications in prostate cancer cells upon long-term androgen ablation and antiandrogen treatmentMARQUES, Rute B; ERKENS-SCHULZE, Sigrun; DE RIDDER, Corrina M et al.International journal of cancer. 2005, Vol 117, Num 2, pp 221-229, issn 0020-7136, 9 p.Article

Deletion of chromosomal region 6q14-16 in prostate cancerVERHAGEN, Paul C. M. S; HERMANS, Karin G. L; BROK, Mariel O et al.International journal of cancer. 2002, Vol 102, Num 2, pp 142-147, issn 0020-7136, 6 p.Article